101 related articles for article (PubMed ID: 2407244)
1. Effect of chronic enalapril treatment on enzymes responsible for the catabolism of angiotensin I and formation of angiotensin II.
Drummer OH; Kourtis S; Johnson H
Biochem Pharmacol; 1990 Feb; 39(3):513-8. PubMed ID: 2407244
[TBL] [Abstract][Full Text] [Related]
2. Formation of angiotensin II and other angiotensin peptides from des-leu 10-angiotensin I in rat lung and kidney.
Drummer OH; Kourtis S; Johnson H
Biochem Pharmacol; 1988 Nov; 37(22):4327-33. PubMed ID: 2848526
[TBL] [Abstract][Full Text] [Related]
3. Sex differences in angiotensin-converting enzyme modulation of Ang (1-7) levels in normotensive WKY rats.
Bhatia K; Zimmerman MA; Sullivan JC
Am J Hypertens; 2013 May; 26(5):591-8. PubMed ID: 23547034
[TBL] [Abstract][Full Text] [Related]
4. Pathways for angiotensin-(1---7) metabolism in pulmonary and renal tissues.
Allred AJ; Diz DI; Ferrario CM; Chappell MC
Am J Physiol Renal Physiol; 2000 Nov; 279(5):F841-50. PubMed ID: 11053044
[TBL] [Abstract][Full Text] [Related]
5. Carboxypeptidase activity common to viridans group streptococci cleaves angiotensin I to angiotensin II: an activity homologous to angiotensin-converting enzyme (ACE).
Harty DWS; Hunter N
Microbiology (Reading); 2011 Jul; 157(Pt 7):2143-2151. PubMed ID: 21546583
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism.
Rice GI; Thomas DA; Grant PJ; Turner AJ; Hooper NM
Biochem J; 2004 Oct; 383(Pt 1):45-51. PubMed ID: 15283675
[TBL] [Abstract][Full Text] [Related]
7. Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors.
Ferrario CM; Jessup J; Gallagher PE; Averill DB; Brosnihan KB; Ann Tallant E; Smith RD; Chappell MC
Kidney Int; 2005 Nov; 68(5):2189-96. PubMed ID: 16221218
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of angiotensin converting enzyme from sheep tissues by captopril, lisinopril and enalapril.
Udupa EG; Rao NM
Indian J Biochem Biophys; 1997 Dec; 34(6):524-8. PubMed ID: 9594434
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin metabolism in rat stomach wall: prevalence of angiotensin-(1-7) formation.
Olszanecki R; Madej J; Suski M; Gebska A; Bujak-Gizycka B; Korbut R
J Physiol Pharmacol; 2009 Mar; 60(1):191-6. PubMed ID: 19439822
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin converting enzyme inhibitors suppress the vascular renin-angiotensin system of spontaneously hypertensive rats.
Higashimori K; Nakamaru M; Tabuchi Y; Nagano M; Mikami H; Ogihara T; Inagami T
Am J Hypertens; 1991 Jan; 4(1 Pt 2):56S-59S. PubMed ID: 2009150
[TBL] [Abstract][Full Text] [Related]
11. Hydrolysis of angiotensin I by peptidases in homogenates of rat lung and aorta.
Johnson H; Drummer OH
Biochem Pharmacol; 1988 Mar; 37(6):1131-6. PubMed ID: 3355587
[TBL] [Abstract][Full Text] [Related]
12. Moexipril, a new angiotensin-converting enzyme (ACE) inhibitor: pharmacological characterization and comparison with enalapril.
Edling O; Bao G; Feelisch M; Unger T; Gohlke P
J Pharmacol Exp Ther; 1995 Nov; 275(2):854-63. PubMed ID: 7473177
[TBL] [Abstract][Full Text] [Related]
13. Inhibitor analysis of angiotensin I-converting and kinin-degrading activities of bovine lung and testicular angiotensin-converting enzyme.
Grinshtein SV; Binevski PV; Gomazkov OA; Pozdnev VF; Nikolskaya II; Kost OA
Biochemistry (Mosc); 1999 Aug; 64(8):938-44. PubMed ID: 10498812
[TBL] [Abstract][Full Text] [Related]
14. Effect of reduced angiotensin-converting enzyme gene expression and angiotensin-converting enzyme inhibition on angiotensin and bradykinin peptide levels in mice.
Campbell DJ; Alexiou T; Xiao HD; Fuchs S; McKinley MJ; Corvol P; Bernstein KE
Hypertension; 2004 Apr; 43(4):854-9. PubMed ID: 14769811
[TBL] [Abstract][Full Text] [Related]
15. A Fluorometric Method of Measuring Carboxypeptidase Activities for Angiotensin II and Apelin-13.
Liu P; Wysocki J; Serfozo P; Ye M; Souma T; Batlle D; Jin J
Sci Rep; 2017 Apr; 7():45473. PubMed ID: 28378780
[TBL] [Abstract][Full Text] [Related]
16. Distribution of Fos-immunoreactivity in rat brain following a dipsogenic dose of captopril and effects of angiotensin receptor blockade.
McKinley MJ; Colvill LM; Giles ME; Oldfield BJ
Brain Res; 1997 Jan; 747(1):43-51. PubMed ID: 9042526
[TBL] [Abstract][Full Text] [Related]
17. Captopril avoids hypertension, the increase in plasma angiotensin II but increases angiotensin 1-7 and angiotensin II-induced perfusion pressure in isolated kidney in SHR.
Castro-Moreno P; Pardo JP; Hernández-Muñoz R; López-Guerrero JJ; Del Valle-Mondragón L; Pastelín-Hernández G; Ibarra-Barajas M; Villalobos-Molina R
Auton Autacoid Pharmacol; 2012 Oct; 32(3 Pt 4):61-9. PubMed ID: 22994939
[TBL] [Abstract][Full Text] [Related]
18. The reduction in alcohol intake produced by enalapril is not attenuated by centrally administered angiotensin inhibitors.
Robertson JM; Harding S; Grupp LA
Alcohol; 1994; 11(4):295-9. PubMed ID: 7945983
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin and bradykinin metabolism by peptidases identified in skeletal muscle.
Ward PE; Russell JS; Vaghy PL
Peptides; 1995; 16(6):1073-8. PubMed ID: 8532591
[TBL] [Abstract][Full Text] [Related]
20. Angiotensinase and vasopressinase activities in hypothalamus, plasma, and kidney after inhibition of angiotensin-converting enzyme: basis for a new working hypothesis.
Villarejo AB; Segarra AB; Ramírez M; Banegas I; Wangensteen R; de Gasparo M; Cobo J; Alba F; Vives F; Prieto I
Horm Metab Res; 2012 Feb; 44(2):152-4. PubMed ID: 22203440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
